Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLP - 1”

381 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 381 results

Early research (Phase 1)Study completedNCT02673554
What this trial is testing

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

Who this might be right for
Type 2 Diabetes
Diabeteszentrum Bad Lauterberg im Harz 30
Not applicableUnknownNCT05268627
What this trial is testing

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss

Who this might be right for
Obesity
Mansoura University 38
Not applicableStudy completedNCT05889637
What this trial is testing

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
Pulmonary Aspiration
The University of Texas Health Science Center, Houston 132
Large-scale testing (Phase 3)Study completedNCT02860923
What this trial is testing

Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy

Who this might be right for
CraniopharyngiomasHypothalamic Obesity
University Hospital, Bordeaux 42
Not applicableStudy completedNCT01938469
What this trial is testing

Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery

Who this might be right for
Gastric Bypass SurgeryObesity
St. Luke's-Roosevelt Hospital Center 33
Post-approval studies (Phase 4)Looking for participantsNCT06774079
What this trial is testing

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

Who this might be right for
Crohn Disease
University of Miami 24
Early research (Phase 1)Study completedNCT01079624
What this trial is testing

GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose

Who this might be right for
PhysiologyGastroenterologyEndocrinology
Uppsala University 15
Not applicableLooking for participantsNCT06725693
What this trial is testing

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

Who this might be right for
GLP1-R-related DiseaseTumorInsulinoma+1 more
Tianjin Medical University 500
Post-approval studies (Phase 4)Study completedNCT01461577
What this trial is testing

Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 89
Not applicableStudy completedNCT02994420
What this trial is testing

Endocrine and Neural Control of Eating in Women

Who this might be right for
Normal Body WeightObesity
University of Zurich 50
Testing effectiveness (Phase 2)Temporarily pausedNCT05478707
What this trial is testing

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Endothelial Dysfunction
University of Virginia 47
Not applicableStudy completedNCT03659461
What this trial is testing

Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusPreDiabetes
National University of Malaysia 174
Not applicableStudy completedNCT00716170
What this trial is testing

GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia

Who this might be right for
Type 2 Diabetes Mellitus
Herlev Hospital 10
Early research (Phase 1)Study completedNCT06634927
What this trial is testing

Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 68
Early research (Phase 1)Study completedNCT00468091
What this trial is testing

Effects of Exendin(9-39) on Gastroduodenal Motility

Who this might be right for
Digestive PhysiologyGastrointestinal MotilityGastrointestinal Hormones+2 more
Ludwig-Maximilians - University of Munich 10
Not applicableNot Yet RecruitingNCT07558603
What this trial is testing

Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist

Who this might be right for
Laxity; Skin
Goldman, Butterwick, Fitzpatrick and Groff 50
Very early researchStudy completedNCT01453842
What this trial is testing

Diet Oil Induced Stimulation of GLP-1

Who this might be right for
Type 2 Diabetes Mellitus
University of Copenhagen 12
Testing effectiveness (Phase 2)Ended earlyNCT00947011
What this trial is testing

Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)

Who this might be right for
Glucose Homeostasis
Johns Hopkins University 12
Testing effectiveness (Phase 2)Looking for participantsNCT07446998
What this trial is testing

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Who this might be right for
Obesity & OverweightMobility DisabilityHOMA-IR
Veru Inc. 200
Post-approval studies (Phase 4)Study completedNCT02537834
What this trial is testing

Tofogliflozin GLP-1 Analogue Combination Trial

Who this might be right for
Type 2 Diabetes Mellitus
Kowa Company, Ltd. 65
Load More Results